1. Jim ON. Tackling drug-resistant infections globally: final report and recommendations. 2016. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf. Accessed 13 Dec 2021.
2. World Health Organization. Global Action Plan on Antimicrobial Resistance. 2015. https://apps.who.int/iris/bitstream/handle/10665/193736/9789241509763_eng.pdf?sequence=1. Accessed 13 Dec 2021.
3. Kusama Y, Tsuzuki S, Muraki Y, Koizumi R, Ishikane M, Ohmagari N. The effects of Japan’s National Action Plan on Antimicrobial Resistance on antimicrobial use. Int J Infect Dis. 2021;103:154–6.
4. World Health Organisation. 2021 Antibacterial agents in clinical and preclinical development: an overview and analysis. 2022. https://www.who.int/publications/i/item/9789240047655. Accessed 1 Jul 2022.
5. Outterson K, Orubu ESF, Rex J, Årdal C, Zaman MH. Patient access in fourteen high-income countries to new antibacterials approved by the FDA, EMA, PMDA, or Health Canada, 2010–2020. Clin Infect Dis. 2021. https://doi.org/10.2139/ssrn.3825520.